Empagliflozin in Patients with Chronic Kidney Disease.

The EMPA-KIDNEY Collaborative Group, Herrington WG, Staplin N, Wanner C, Green JB, Hauske SJ, Emberson JR, Preiss D, Judge P, Mayne KJ, Ng SYA, Sammons E, Zhu D, Hill M, Stevens W, Wallendszus K, Brenner S, Cheung AK, Liu ZH, Li J, Hooi LS, Liu W, Kadowaki T, Nangaku M, Levin A, Cherney D, Maggioni AP, Pontremoli R, Deo R, Goto S, Rossello X, Tuttle KR, Steubl D, Petrini M, Massey D, Eilbracht J, Brueckmann M, Landray MJ, Baigent C, Haynes R

Open source

DOI: 10.1056/nejmoa2204233
Published: 2023 Jan 12
Container: The New England journal of medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa2204233,
  title = {Empagliflozin in Patients with Chronic Kidney Disease.},
  author = {The EMPA-KIDNEY Collaborative Group and Herrington WG and Staplin N and Wanner C and Green JB and Hauske SJ and Emberson JR and Preiss D and Judge P and Mayne KJ and Ng SYA and Sammons E and Zhu D and Hill M and Stevens W and Wallendszus K and Brenner S and Cheung AK and Liu ZH and Li J and Hooi LS and Liu W and Kadowaki T and Nangaku M and Levin A and Cherney D and Maggioni AP and Pontremoli R and Deo R and Goto S and Rossello X and Tuttle KR and Steubl D and Petrini M and Massey D and Eilbracht J and Brueckmann M and Landray MJ and Baigent C and Haynes R},
  year = {2023},
  journal = {The New England journal of medicine},
  doi = {10.1056/nejmoa2204233},
  url = {https://doi.org/10.1056/nejmoa2204233}
}

RIS

TY  - JOUR
TI  - Empagliflozin in Patients with Chronic Kidney Disease.
AU  - The EMPA-KIDNEY Collaborative Group
AU  - Herrington WG
AU  - Staplin N
AU  - Wanner C
AU  - Green JB
AU  - Hauske SJ
AU  - Emberson JR
AU  - Preiss D
AU  - Judge P
AU  - Mayne KJ
AU  - Ng SYA
AU  - Sammons E
AU  - Zhu D
AU  - Hill M
AU  - Stevens W
AU  - Wallendszus K
AU  - Brenner S
AU  - Cheung AK
AU  - Liu ZH
AU  - Li J
AU  - Hooi LS
AU  - Liu W
AU  - Kadowaki T
AU  - Nangaku M
AU  - Levin A
AU  - Cherney D
AU  - Maggioni AP
AU  - Pontremoli R
AU  - Deo R
AU  - Goto S
AU  - Rossello X
AU  - Tuttle KR
AU  - Steubl D
AU  - Petrini M
AU  - Massey D
AU  - Eilbracht J
AU  - Brueckmann M
AU  - Landray MJ
AU  - Baigent C
AU  - Haynes R
PY  - 2023
JO  - The New England journal of medicine
DO  - 10.1056/nejmoa2204233
UR  - https://doi.org/10.1056/nejmoa2204233
ER  -

APA

Group, T. E. C., WG, H., N, S., C, W., JB, G., SJ, H., JR, E., D, P., P, J., KJ, M., SYA, N., E, S., D, Z., M, H., W, S., K, W., S, B., AK, C., ZH, L., J, L., LS, H., W, L., T, K., M, N., A, L., D, C., AP, M., R, P., R, D., S, G., X, R., KR, T., D, S., M, P., D, M., J, E., M, B., MJ, L., C, B., & R, H. (2023). Empagliflozin in Patients with Chronic Kidney Disease.. The New England journal of medicine. https://doi.org/10.1056/nejmoa2204233

Source records

pubmed · retrieved 2026-09-25T01:47:01.852Z